122 related articles for article (PubMed ID: 23219421)
1. Measuring the specific activity of the protein tyrosine phosphatase Lyp.
Bayley R; Yang P; Buckley CD; Young SP
J Immunol Methods; 2013 Feb; 388(1-2):33-9. PubMed ID: 23219421
[TBL] [Abstract][Full Text] [Related]
2. Measuring the specific activity of the CD45 protein tyrosine phosphatase.
Rider DA; Young SP
J Immunol Methods; 2003 Jun; 277(1-2):127-34. PubMed ID: 12799045
[TBL] [Abstract][Full Text] [Related]
3. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X
J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the
Perry DJ; Peters LD; Lakshmi PS; Zhang L; Han Z; Wasserfall CH; Mathews CE; Atkinson MA; Brusko TM
J Immunol; 2021 Aug; 207(3):849-859. PubMed ID: 34301848
[TBL] [Abstract][Full Text] [Related]
5. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643
[TBL] [Abstract][Full Text] [Related]
6. Gold(I) phosphine mediated selective inhibition of lymphoid tyrosine phosphatase.
Karver MR; Krishnamurthy D; Bottini N; Barrios AM
J Inorg Biochem; 2010 Mar; 104(3):268-73. PubMed ID: 20083307
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and functional studies of lymphoid-specific tyrosine phosphatase (Lyp) variants S201F and R266W.
Liu J; Chen M; Li R; Yang F; Shi X; Zhu L; Wang HM; Yao W; Liu Q; Meng FG; Sun JP; Pang Q; Yu X
PLoS One; 2012; 7(8):e43631. PubMed ID: 22952725
[TBL] [Abstract][Full Text] [Related]
8. Target-specific control of lymphoid-specific protein tyrosine phosphatase (Lyp) activity.
Walton ZE; Bishop AC
Bioorg Med Chem; 2010 Jul; 18(14):4884-91. PubMed ID: 20594861
[TBL] [Abstract][Full Text] [Related]
9. Identification of substrates of human protein-tyrosine phosphatase PTPN22.
Wu J; Katrekar A; Honigberg LA; Smith AM; Conn MT; Tang J; Jeffery D; Mortara K; Sampang J; Williams SR; Buggy J; Clark JM
J Biol Chem; 2006 Apr; 281(16):11002-10. PubMed ID: 16461343
[TBL] [Abstract][Full Text] [Related]
10. The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation.
Hill RJ; Zozulya S; Lu YL; Ward K; Gishizky M; Jallal B
Exp Hematol; 2002 Mar; 30(3):237-44. PubMed ID: 11882361
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD45 lacking the catalytic protein tyrosine phosphatase domain modulates Lck phosphorylation and T cell activation.
Wang Y; Johnson P
J Biol Chem; 2005 Apr; 280(14):14318-24. PubMed ID: 15687496
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
Du J; Qiao Y; Sun L; Wang X
Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
[TBL] [Abstract][Full Text] [Related]
13. Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes.
Perri V; Pellegrino M; Ceccacci F; Scipioni A; Petrini S; Gianchecchi E; Lo Russo A; De Santis S; Mancini G; Fierabracci A
PLoS One; 2017; 12(4):e0175784. PubMed ID: 28437437
[TBL] [Abstract][Full Text] [Related]
14. The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses.
Vang T; Landskron J; Viken MK; Oberprieler N; Torgersen KM; Mustelin T; Tasken K; Tautz L; Rickert RC; Lie BA
Hum Immunol; 2013 May; 74(5):574-85. PubMed ID: 23333624
[TBL] [Abstract][Full Text] [Related]
15. Thiuram disulfides as pseudo-irreversible inhibitors of lymphoid tyrosine phosphatase.
Kulkarni RA; Stanford SM; Vellore NA; Krishnamurthy D; Bliss MR; Baron R; Bottini N; Barrios AM
ChemMedChem; 2013 Sep; 8(9):1561-8. PubMed ID: 23873737
[TBL] [Abstract][Full Text] [Related]
16. [Research progress of several protein tyrosine phosphatases in diabetes].
Chen M; Sun JP; Liu J; Yu X
Sheng Li Xue Bao; 2010 Apr; 62(2):179-89. PubMed ID: 20401454
[TBL] [Abstract][Full Text] [Related]
17. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background.
Zikherman J; Hermiston M; Steiner D; Hasegawa K; Chan A; Weiss A
J Immunol; 2009 Apr; 182(7):4093-106. PubMed ID: 19299707
[TBL] [Abstract][Full Text] [Related]
18. Modulation of CD45 tyrosine phosphatase activity by antigen.
Lago Paz F; Galgani M; D'Oro U; Matarese G; Masci AM; Zappacosta S; Racioppi L
Eur J Immunol; 2001 Mar; 31(3):777-82. PubMed ID: 11241282
[TBL] [Abstract][Full Text] [Related]
19. Regulation of lymphoid tyrosine phosphatase activity: inhibition of the catalytic domain by the proximal interdomain.
Liu Y; Stanford SM; Jog SP; Fiorillo E; Orrú V; Comai L; Bottini N
Biochemistry; 2009 Aug; 48(31):7525-32. PubMed ID: 19586056
[TBL] [Abstract][Full Text] [Related]
20. CD4+ lymphocytes from HIV-infected patients display impaired CD45-associated tyrosine phosphatase activity which is enhanced by anti-oxidants.
Cayota A; Vuillier F; Gonzalez G; Dighiero G
Clin Exp Immunol; 1996 Apr; 104(1):11-7. PubMed ID: 8603515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
